Clinical Trial Update: Clinical Trial for Ovarian Cancer (OvaRex®) [Phase 3]

View source ↗

Summary

Phase 3 trial of OvaRex for ovarian cancer has been terminated (status TERMINATED) per clinicaltrials.gov; sponsor is Unither Pharmaceuticals.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• OvaRex

Snippet

Sponsor: Unither Pharmaceuticals | Conditions: Ovarian Cancer | Phase 3 | Status: TERMINATED